Sasha Gentling, CFA Joins BioSig as Director of Business Development

November 6, 2019

BioSig Appoints Andrew Ballou as Vice President of Investor Relations

October 29, 2019

BioSig Opens a Technology Development Office in Rochester, MN

October 15, 2019

BioSig to Participate at The 14th Annual International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy

October 10, 2019

BioSig to Present Clinical Observations at Venice Arrhythmias 2019

September 30, 2019

Global Marketing and Strategy Leader Martha Pease Joins BioSig Board of Directors

September 26, 2019

BioSig Technologies Signs a New Licensing Agreement with Mayo Clinic

September 12, 2019

BioSig‘s Subsidiary NeuroClear Technologies, Inc. Raises $3.7 million

September 5, 2019

BioSig Allowed Additional Foundational US Patent for its PURE EP(tm) System

August 1, 2019

Julie Stephenson Joins BioSig as Senior Director of Clinical Affairs

July 24, 2019